MOESM1 of Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease

Additional file 1: Table S1. Summary of human cases used in this study. Table S2. Serum proteome profiling of AD and control cases by TMT–LC/LC-MS/MS. Table S3. Dynamic range analysis based on plasma proteome database concentration and MS-derived abundance index. Table S4. Differentially expressed serum proteins in AD and control cases by TMT–LC/LC-MS/MS.